Details for New Drug Application (NDA): 200177
✉ Email this page to a colleague
NDA 200177 describes DIETHYLPROPION HYDROCHLORIDE, which is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs, and is included in ten NDAs. It is available from eleven suppliers. Additional details are available on the DIETHYLPROPION HYDROCHLORIDE profile page.
The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
Summary for 200177
| Tradename: | DIETHYLPROPION HYDROCHLORIDE |
| Applicant: | Lannett Co Inc |
| Ingredient: | diethylpropion hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 200177
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Medical Subject Heading (MeSH) Categories for 200177
Suppliers and Packaging for NDA: 200177
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 200177 | ANDA | Lannett Company, Inc. | 0527-1475 | 0527-1475-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0527-1475-01) |
| DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 200177 | ANDA | Chartwell RX, LLC. | 62135-488 | 62135-488-90 | 90 TABLET in 1 BOTTLE (62135-488-90) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Jul 18, 2011 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
